It's our need to understand and declare that "we've figured it out".
I don't think CELADON was buying as they got hit and retreated to .0014, they could have been bid-whacking...impossible to know.
I do know this, the agreement states:
"4. General Release of All Claims by the Fund.
a) As of no later than January 1, 2018 and upon the absence,"
of any breach of the agreement by JPEX, Auctus, will release JPEX of any and all claims as long as JPEX keeps their word regarding the terms (availability of shares).
I doubt the plan is $954 per day.
You can read the full agreement:
https://www.sec.gov/Archives/edgar/data/1506814/000139160917000206/ex101_settlementagmnt.htm
Recent JPEX News
- Form QUALIF - Notice of Qualification [Regulation A] • Edgar (US Regulatory) • 10/02/2023 04:15:09 AM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 09/28/2023 03:54:46 PM
- Form 1-A/A - Offering Statement [Regulation A]: [Amend] • Edgar (US Regulatory) • 09/12/2023 06:32:39 PM
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM